Table 2.

General attitudes towards the regulation of PGT

From 1 (fully opposing) to 10 (fully supporting)	Israel (n = 18)		Spain (n = 18)
From 1 (fully opposing) to 10 (fully supporting)	Mean	SD	Mean	SD
1. The public sector should aim at reducing regulation regarding PGT to a minimum in order to allow the patients maximum free choice	3.4	2.83	3.7	2.79
2. When performing PGT for medical reasons, sex selection as an add-on service should be allowed. In other words, the physician may reveal the sex of the (clinically) selected embryos enabling the patients to choose	2.8	2.76	2.2	1.63
3. When performing IVF due to infertility, regulation should be more tolerant towards PGT. It should be allowed as an add-on service to IVF for some range of disorders	7.9	2.51	6.3	2.66
4. It is viable in terms of regulation to separate between the use of PGT-A and the use of PGT-M or PGT-SR for detecting disorders. In other words, in case PGT-A will eventually become a very common add-on for IVF cycles to increase the prospects of the treatment, regulation may still prevent the clinics from regularly using these biopsies for PGT-M or PGT-SR	4.8	2.25	5.6	2.37